Study on the Effect of Apatinib Mesylate in the Treatment of Patients with Advanced Primary Hepatocellular Carci-noma and the Effect on Serum Vascular Endothelial Growth Factor and Hypoxia-inducible Factor-1α Levels

Lu Mingyue

doi:10.3969/j.issn.1004-5775.2023.13.014

Home>Articles>Study on the Effect of Apatinib Mesylate in the Treatment of Patients with Advanced Primary Hepatocellular Carci-noma and the Effect on Serum Vascular Endothelial Growth Factor and Hypoxia-inducible Factor-1α Levels

DOI: 10.3969/j.issn.1004-5775.2023.13.014

Study on the Effect of Apatinib Mesylate in the Treatment of Patients with Advanced Primary Hepatocellular Carci-noma and the Effect on Serum Vascular Endothelial Growth Factor and Hypoxia-inducible Factor-1α Levels

Lu Mingyue

Keywords：Apatinib mesylatePrimary liver cancerTransarterial chemoembolization with drug-laden microspheresVascular endothelial growth factorSurvival

Publication Date：2023-07-15

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 1584-1587 )

HEILONG MEDICAL JOURANL

ISSN：1004-5775

Year, Vol.(Issue)：2023,47(13)